12 Sep, 2025
5 JAK Inhibitor Side Effects You Can’t Ignore if You Have Rheumatoid Arthritis
Drug side effects , , , , , ,

JAK inhibitor side effects in rheumatoid arthritis
Image credit: Unsplash

Introduction

JAK inhibitors, such as tofacitinib (Xeljanz) and baricitinib (Olumiant), are oral medications used to treat rheumatoid arthritis (RA). They target Janus kinase (JAK) pathways to reduce inflammation. While effective, they have raised safety concerns. In fact, the FDA has issued warnings about serious risks, especially in older patients. Knowing the most important JAK inhibitor side effects in rheumatoid arthritis helps patients and doctors make informed decisions (FDA Safety Communication).

1. Increased Risk of Infections

Like biologics, JAK inhibitors weaken the immune system. Patients may be more vulnerable to respiratory infections, shingles, or urinary tract infections. Some infections can become severe or even life-threatening.

2. Cardiovascular Risks

One of the most concerning JAK inhibitor adverse effects in RA is an increased risk of heart attack, stroke, and blood clots. This risk is higher in elderly patients or those with pre-existing cardiovascular disease.

3. Cancer Risk

Long-term use of JAK inhibitors may raise the risk of certain cancers, including lymphoma and lung cancer. The FDA specifically highlighted this concern for patients over 50 who have additional risk factors.

4. Gastrointestinal Perforations

Rarely, JAK inhibitors can cause serious gastrointestinal problems such as stomach or intestinal perforations. Patients should seek medical help if they experience severe abdominal pain or persistent digestive symptoms.

5. Other Common Side Effects

More frequent but less severe problems include headache, diarrhea, and increased cholesterol levels. These are manageable but should be monitored during regular checkups.

Conclusion

JAK inhibitors have improved the lives of many rheumatoid arthritis patients, but their use requires caution. Awareness of JAK inhibitor side effects in rheumatoid arthritis—from infections to cardiovascular risks—is essential. Patients should have regular blood tests, report unusual symptoms promptly, and discuss their risk factors with a rheumatologist.